Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid A is the highly conserved, hydrophobic anchor of lipopolysaccharide (LPS), which forms the outer leaflet of the Gram-negative bacterial outer membrane. The phosphate groups at the 1 and 4' positions of the Lipid A disaccharide backbone carry negative charges that are crucial for the structural integrity of the membrane, as they bridge with divalent cations like Mg2+ and Ca2+ (PubMed: 11014202). These phosphate groups are the primary molecular target for polymyxin antibiotics, such as Colistin and Polymyxin B, which act by binding to these sites and displacing the stabilizing cations (StatPearls: NBK513277). This interaction causes significant disruption of the outer membrane and subsequent damage to the inner cytoplasmic membrane, leading to bacterial cell death. Beyond its structural role, Lipid A is the endotoxic moiety of LPS, triggering potent inflammatory responses through the TLR4/MD-2 complex in humans (PubMed: 24037437). Consequently, modifications to these phosphate groups, such as the addition of phosphoethanolamine or 4-amino-4-deoxy-L-arabinose, are a major mechanism of bacterial resistance to polymyxins (PubMed: 27337313). Targeting these phosphate groups remains a critical strategy for treating multidrug-resistant Gram-negative infections, although the clinical use of such drugs is often limited by nephrotoxicity and neurotoxicity.
Polymyxins bind electrostatically to the negatively charged phosphate groups of Lipid A, displacing divalent cations (Mg2+ and Ca2+) that stabilize the lipopolysaccharide layer. This competitive displacement disrupts the outer membrane, increases permeability, and subsequently damages the inner cytoplasmic membrane, leading to the leakage of intracellular contents and bacterial cell death (PubMed: 24777357).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid A phosphate groups of lipopolysaccharide (Lipid A phosphate).